Skip to main content
. 2023 Jan 20;28(3):1039. doi: 10.3390/molecules28031039

Figure 5.

Figure 5

Schematic illustration of baicalein-induced G2/M cell cycle arrest in ErbB2-positive ovarian cancer cells via activation of the ATM/CHK2/CDC25C signaling axis. Treatment of ovarian cancer cells with baicalein induces ROS generation, causes DNA double-strand breaks, and triggers the DNA damage response to ATM signaling to arrest cell cycle progression at the G2/M phase. Blue font represents an increase, and orange font represents a decrease.